Vidicetizumab

Mixed feelings? Take stock of the commercialization progress of the first batch of new drugs in the world in 2021
Agironse injection Vidicetizumab Les Pran Fosun Kate Fosun Pharma Corning Jerry Pharmaceuticals Tengsheng Bo medicine Elise Pharma Rongchang Biology nmpa
04-25
China's first ADC for the treatment of urinary urothelial cancer is coming! Rongchang Bio vidicetizumab new indications were approved for listing
Vidicetizumab Urinary tract carcinoma Rongchang Biology State Food and Drug Administration of China her2
01-06
The new version of the medical insurance directory is implemented! Rongchang Bio Tai Ai and Edich issued the first medical insurance prescription
Vidicetizumab Rongchang Biology Edich Tai Ai Systemic lupus erythematosus Tatta Sip
01-05
"2" new drugs have attracted the most attention: the approval of anti-tumor drugs has been accelerated, and rare disease drugs have been included in medical insurance
Rare disease drugs Antitumor drugs drugs Vidicetizumab
12-31
In 2021, more than 30 new drugs will be listed through priority review, and oncology drugs will still be the main line of domestic innovation
Tumor drugs Vidicetizumab drugs Rongchang Biology tumor
12-30